Guideline for the Diagnostic Approach and Management of A patient with Myasthenia Gravis
MoH/DGKH/GUD/0.05/Vers.02 | Khawla Hospital
Type
Regulatory
Agency
Oman Ministry of Health
Issued on
19 Mar 2025 (corresponding to 19 Ramadan 1446 H)
Jurisdiction
Oman
Taxonomy
General Health Law, Medical Procedure & Treatment, Pharmacy, Drugs & Medicinal Products
Acronyms
AChR | Acetylcholine receptor |
ChEI | Choline esterase inhibitors |
CMAP | Compound Muscle action potential |
CT | Computerized Tomography Scan |
EMG | Electromyography |
GMG | Generalized myasthenia gravis |
IVIg | Intravenous immunoglobulin |
IS | Immune suppressants |
MG | Myasthenia Gravis |
MGFA | Myasthenia Gravis Foundation of America |
MND | Motor Neuron Disease |
MRI | Magnetic Resonance Imaging |
MUAP | Motor Unit Action Potential |
MuSK | Muscle specific tyrosine kinase |
NCS | Nerve Conduction Study |
NMJ | Neuromuscular junction |
PLEX | Plasma exchange |
OMG | Ocular myasthenia gravis |
QMGS | quantitative myasthenia gravis score |
RCT | Randomized Controlled Trials |
RNS | Repetitive nerve stimulation |
SFEMG | Single Fiber Electromypgraphy |
SNAP | Sensory Action potential |
SNMG | Sero-Negative Myasthenia Gravis |